Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study.

ABSTRACT:

SUBMITTER: Bastos-Oreiro M 

PROVIDER: S-EPMC11792173 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature